核苷类似物-话题@MedSci

#核苷类似物#

10篇内容 | 994人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2223384, encodeId=26482223384a7, content=<a href='/topic/show?id=88f780e80a4' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素-α#</a> <a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a> <a href='/topic/show?id=eab9113242fc' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎（CHB）#</a>, objectTitle=（关联下专家和医院）J Hepatol：聚乙二醇干扰素α-2a减少HBeAg阴性患者核苷(酸)类似物停药后的复发, objectType=article, longId=841235, objectId=49e284123522, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867598346_4754896.jpeg, objectUrl=/article/show_article.do?id=49e284123522, replyNumber=0, likeNumber=70, createdTime=2024-08-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=49e284123522, moduleTitle=（关联下专家和医院）J Hepatol：聚乙二醇干扰素α-2a减少HBeAg阴性患者核苷(酸)类似物停药后的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49e284123522)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2049617, encodeId=d25c204961ed0, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率, objectType=article, longId=209258, objectId=9b01209258ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b01209258ab, replyNumber=0, likeNumber=104, createdTime=2021-11-20, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b01209258ab, moduleTitle=Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b01209258ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049616, encodeId=13a42049616c7, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=Science：新方法可更快更廉价地合成治疗病毒感染和癌症的核苷类似物, objectType=article, longId=199240, objectId=15b6199240b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15b6199240b6, replyNumber=0, likeNumber=92, createdTime=2021-06-23, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15b6199240b6, moduleTitle=Science：新方法可更快更廉价地合成治疗病毒感染和癌症的核苷类似物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15b6199240b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049614, encodeId=7ba620496143d, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=Clinica Chimica Acta：白蛋白-胆红素评分与慢性乙型肝炎患者对聚乙二醇化干扰素和核苷类似物的反应有关, objectType=article, longId=192144, objectId=eefa19214401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eefa19214401, replyNumber=0, likeNumber=89, createdTime=2020-08-28, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eefa19214401, moduleTitle=Clinica Chimica Acta：白蛋白-胆红素评分与慢性乙型肝炎患者对聚乙二醇化干扰素和核苷类似物的反应有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eefa19214401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049615, encodeId=e372204961510, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=一款COVID-19的潜在疗法：糖核苷类似物EIDD-2801，已启动II期临床试验, objectType=article, longId=196221, objectId=32501962219e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32501962219e, replyNumber=0, likeNumber=84, createdTime=2021-01-18, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32501962219e, moduleTitle=一款COVID-19的潜在疗法：糖核苷类似物EIDD-2801，已启动II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32501962219e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049613, encodeId=f18e20496136d, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=Liver International：长期使用核苷类似物对慢性乙型肝炎患者脂肪因子与肝脂肪变性和纤维化的影响, objectType=article, longId=176258, objectId=f2141e6258a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2141e6258a4, replyNumber=0, likeNumber=87, createdTime=2019-11-15, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2141e6258a4, moduleTitle=Liver International：长期使用核苷类似物对慢性乙型肝炎患者脂肪因子与肝脂肪变性和纤维化的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2141e6258a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049612, encodeId=5eea204961295, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=Blood：预防性核苷类似物治疗可降低乙肝复发风险, objectType=article, longId=151643, objectId=b5a615164348, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5a615164348, replyNumber=0, likeNumber=112, createdTime=2019-09-25, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5a615164348, moduleTitle=Blood：预防性核苷类似物治疗可降低乙肝复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5a615164348)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049611, encodeId=c92b204961183, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=Antivir Ther：雷特格韦与两个核苷类似物联合抗逆转录病毒治疗, objectType=article, longId=49596, objectId=ce8c4959605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce8c4959605, replyNumber=0, likeNumber=77, createdTime=2015-07-06, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce8c4959605, moduleTitle=Antivir Ther：雷特格韦与两个核苷类似物联合抗逆转录病毒治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce8c4959605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049610, encodeId=98c82049610ed, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=JCO：曹广文等发现核苷/核苷类似物可改善乙肝病毒相关肝细胞癌患者术后生存, objectType=article, longId=24198, objectId=a44224198b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a44224198b3, replyNumber=0, likeNumber=96, createdTime=2013-12-05, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a44224198b3, moduleTitle=JCO：曹广文等发现核苷/核苷类似物可改善乙肝病毒相关肝细胞癌患者术后生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a44224198b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049609, encodeId=1a9d2049609ef, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=JAMA：核苷类似物可使HBV相关肝癌切除术后复发风险降低, objectType=article, longId=13090, objectId=9a61130909c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a61130909c, replyNumber=0, likeNumber=92, createdTime=2013-08-24, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a61130909c, moduleTitle=JAMA：核苷类似物可使HBV相关肝癌切除术后复发风险降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a61130909c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2049608, encodeId=efe8204960830, content=<a href='/topic/show?id=5bf5621463a' target=_blank style='color:#2F92EE;'>#核苷类似物#</a>, objectTitle=JGH：α-干扰素联合核苷类似物应用可有效清除乙肝抗原, objectType=article, longId=3505, objectId=51dc35055a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51dc35055a, replyNumber=0, likeNumber=93, createdTime=2012-03-12, rootId=0, userName=villahu, userId=bf1b289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51dc35055a, moduleTitle=JGH：α-干扰素联合核苷类似物应用可有效清除乙肝抗原, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51dc35055a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

核苷类似物

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素-α# #核苷类似物# #慢性乙型肝炎（CHB）#

（关联下专家和医院）J Hepatol：聚乙二醇干扰素α-2a减少HBeAg阴性患者核苷(酸)类似物停药后的复发

2024-08-31发表于上海

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率

2021-11-20

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

Science：新方法可更快更廉价地合成治疗病毒感染和癌症的核苷类似物

2021-06-23

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

Clinica Chimica Acta：白蛋白-胆红素评分与慢性乙型肝炎患者对聚乙二醇化干扰素和核苷类似物的反应有关

2020-08-28

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

一款COVID-19的潜在疗法：糖核苷类似物EIDD-2801，已启动II期临床试验

2021-01-18

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

Liver International：长期使用核苷类似物对慢性乙型肝炎患者脂肪因子与肝脂肪变性和纤维化的影响

2019-11-15

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

Blood：预防性核苷类似物治疗可降低乙肝复发风险

2019-09-25

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

Antivir Ther：雷特格韦与两个核苷类似物联合抗逆转录病毒治疗

2015-07-06

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

JCO：曹广文等发现核苷/核苷类似物可改善乙肝病毒相关肝细胞癌患者术后生存

2013-12-05

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

JAMA：核苷类似物可使HBV相关肝癌切除术后复发风险降低

2013-08-24

villahu (审核中...)

前往app查看评论内容

#核苷类似物#

JGH：α-干扰素联合核苷类似物应用可有效清除乙肝抗原

2012-03-12

科室
- - 订阅+
  - 更多科室
工具
服务